P5-19-06: Highly Effective of Gemcitabine and Cisplatin (GP) as First-Line Combination Therapy in Patients with Triple-Negative Metastatic Breast Cancer: Final Report of a Phase II Trial.

Mapping Intimacies ◽

10.1158/0008-5472.sabcs11-p5-19-06 ◽

2011 ◽

Cited By ~ 1

Author(s):

Z Wang ◽

X Hu ◽

B Wang ◽

L Wang ◽

J Zhang ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Combination Therapy ◽

Phase Ii ◽

Triple Negative ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Final Report ◽

First Line ◽

Gemcitabine And Cisplatin

Download Full-text

Efficacy of gemcitabine and cisplatin (GP) as first-line combination therapy in patients with triple-negative metastatic breast cancer: Preliminary results report of a phase II trial.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.1100 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 1100-1100 ◽

Cited By ~ 2

Author(s):

Z. Wang ◽

X. Hu ◽

L. Chen ◽

J. Wang ◽

H. Wang ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Combination Therapy ◽

Phase Ii ◽

Triple Negative ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

Preliminary Results ◽

Gemcitabine And Cisplatin

Download Full-text

Phase II Trial of Weekly Vinorelbine and Trastuzumab as First‐Line Therapy in Patients with HER2 + Metastatic Breast Cancer

The Oncologist ◽

10.1634/theoncologist.7-5-410 ◽

2002 ◽

Vol 7 (5) ◽

pp. 410-417 ◽

Cited By ~ 107

Author(s):

Mohammad Jahanzeb ◽

Joanne E. Mortimer ◽

Furhan Yunus ◽

David H. Irwin ◽

James Speyer ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Line Therapy

Download Full-text

First-line chemotherapy of advanced or metastatic breast cancer (MBC) with docetaxel and doxorubicin in Indonesia: results from A phase II trial

Medical Journal of Indonesia ◽

10.13181/mji.v14i1.166 ◽

2005 ◽

pp. 20

Author(s):

Abdulmuthalib Abdulmuthalib ◽

Idral Darwis ◽

Nugroho Prayogo ◽

Sutjipto Sutjipto

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

Line Chemotherapy

Download Full-text

Randomized Phase II Trial of Weekly vs. Every 2 Weeks vs. Every 3 Weeks Nanoparticle Albumin-Bound Paclitaxel With Bevacizumab as First-Line Chemotherapy for Metastatic Breast Cancer

Clinical Breast Cancer ◽

10.1016/j.clbc.2013.02.008 ◽

2013 ◽

Vol 13 (4) ◽

pp. 239-246.e1 ◽

Cited By ~ 19

Author(s):

Andrew D. Seidman ◽

Alison K. Conlin ◽

Ariadne Bach ◽

Mary Ellen Moynahan ◽

Diana Lake ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

Randomized Phase Ii ◽

Line Chemotherapy

Download Full-text

First-Line Bevacizumab (Bev) Combination Therapy in Triple-Negative (TN) Locally Recurrent/Metastatic Breast Cancer (LR/MBC): Subpopulation Analysis of Study MO19391 in >2000 Patients (Pts).

10.1158/0008-5472.sabcs-09-6093 ◽

2009 ◽

Cited By ~ 5

Author(s):

C. Thomssen ◽

J. Pierga ◽

K. Pritchard ◽

L. Biganzoli ◽

H. Cortes-Funes ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Combination Therapy ◽

Triple Negative ◽

Metastatic Breast ◽

First Line ◽

Locally Recurrent

Download Full-text

Phase II Trial with Gemcitabine, Paclitaxel and Bevacizumab for the First Line Treatment of Metastatic Breast Cancer.

10.1158/0008-5472.sabcs-09-6089 ◽

2009 ◽

Cited By ~ 2

Author(s):

A. Guardino ◽

M. Chen ◽

M. Levy ◽

C. Chen

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

P5-19-03: Albumin-Bound Paclitaxel (ab-pac) Versus Docetaxel for First-Line Treatment of Metastatic Breast Cancer (MBC): Overall Survival and Safety Analysis of a Randomized Phase II Trial.

10.1158/0008-5472.sabcs11-p5-19-03 ◽

2011 ◽

Cited By ~ 1

Author(s):

WJ Gradishar ◽

D Krasnojon ◽

S Cheporov ◽

AN Makhson ◽

GM Manikhas ◽

...

Keyword(s):

Breast Cancer ◽

Overall Survival ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

P1-17-07: Phase II Trial of RAD001 Plus Carboplatin in Patients with Triple-Negative Metastatic Breast Cancer.

10.1158/0008-5472.sabcs11-p1-17-07 ◽

2011 ◽

Author(s):

JC Singh ◽

S Stein ◽

M Volm ◽

J Smith ◽

Y Novik ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Triple Negative ◽

Phase Ii Trial ◽

Metastatic Breast

Download Full-text

P1-14-01: Randomized Phase II Trial of Weekly vs. q 2-Weekly vs. q 3-Weekly Nanoparticle Albumin-Bound Paclitaxel with Bevacizumab as First-Line Therapy for Metastatic Breast Cancer.

10.1158/0008-5472.sabcs11-p1-14-01 ◽

2011 ◽

Author(s):

AD Seidman ◽

AK Conlin ◽

A Bach ◽

A Forero-Torres ◽

G Wright ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Download Full-text

Abstract P5-20-10: Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer: Preliminary Results of a Phase II Trial of the Sarah Cannon Research Institute

10.1158/0008-5472.sabcs12-p5-20-10 ◽

2012 ◽

Author(s):

DA Yardley ◽

P Ward ◽

C Handricks ◽

B Daniel ◽

W Harwin ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Triple Negative ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Preliminary Results ◽

Research Institute

Download Full-text